C4 Therapeutics Inc (CCCC) support and resistance · rev $35.6M
C4 Therapeutics Inc (CCCC) is a biotechnology company listed on US.
This page maps C4 Therapeutics Inc (CCCC) support and resistance from cached range and valuation — not a live tape and not a trade alert.
Latest reported CCCC revenue for 2024-12-31 was $35.6M. Net income was -$105.3M. Revenue was up 71.4% from 2023-12-31 to 2024-12-31. CCCC currently screens at market cap $425.7M.
CCCC currently screens at market cap $425.7M. Round numbers near that cap and multiple often act as psychological resistance; prior-period revenue is the fundamental floor traders argue about.
A new CCCC 8-K or 10-Q can move the levels that matter more than a drawing on a chart.
Not investment advice. Use the CCCC quote page for the session range and the stock page for the full model.
Not investment advice.